Author

H. S. Alvarez-Manzo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:bacteria (other)· 1 Assay:proteomics· 1

Frequent Co-Authors

B. Nguyen· 1 shared J. Anthony· 1 shared J. Van Cauwelaert de Wyels· 1 shared K. L. Cotten· 1 shared K. M. Davis· 1 shared R. K. Davidson· 1 shared T. van Opijnen· 1 shared W. Shi· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

B. Nguyen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivNov 1, 2021

Yersinia pseudotuberculosis doxycycline tolerance strategies include modulating expression of genes involved in cell permeability and tRNA modifications

H. S. Alvarez-Manzo, R. K. Davidson, J. Van Cauwelaert de Wyels…·K. M. Davis

This study identifies gene expression changes in Yersinia pseudotuberculosis in response to doxycycline, showing that OmpF porin and TusB tRNA modification influence antibiotic tolerance.

DOI 10.1371/journal.ppat.1010556

bacteria (other)proteomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintFeb 4, 2021

Nitroxoline as a promising alternative drug for the treatment of Lyme disease based on an in-vitro study

H. S. Alvarez-Manzo, Y. Zhang, W. Shi, Y. Zhang

This study evaluates nitroxoline's effectiveness against persistent Borrelia burgdorferi in vitro, showing it is as active as cefuroxime and effective in combination therapies.

DOI 10.1101/2021.02.04.429852

experimental assayhost-pathogen & immune response

𝕏 PostBluesky